# BIO BLAST PHARMA LTD.: Form D filings

BIO BLAST PHARMA LTD., a pharmaceuticals company in New Haven, CT, filed 2 Form D notices with the SEC between 2014 and 2016. The latest, on April 1, 2016, reports $6.7 million sold of a $6.7 million offering to 4 investors.

Find out what BIO BLAST PHARMA LTD. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20BIO%20BLAST%20PHARMA%20LTD.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=BIO%20BLAST%20PHARMA%20LTD.&page=%2Fdata%2Fform-d%2Fcompany%2Fbio-blast-pharma-ltd-1596812)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20BIO%20BLAST%20PHARMA%20LTD.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=BIO%20BLAST%20PHARMA%20LTD.&page=%2Fdata%2Fform-d%2Fcompany%2Fbio-blast-pharma-ltd-1596812)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Connecticut](https://specstream.ai/data/form-d/state/connecticut): 428 rows, by operating companies, filed since November 1, 2024, $21.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/connecticut
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: CONNECTICUT FINANCIAL CENTER, 157 CHURCH STREET (19TH FLOOR), New Haven, CT, 06510
- Phone: (475) 655-3032
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Israel
- Year incorporated: 2012
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1596812

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 1, 2016 | New notice | $6,699,999 | $6,699,999 | $0 | 4 | Mar 22, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1596812/000114420416092293/0001144204-16-092293-index.htm) |
| Feb 13, 2014 | New notice | $4,750,000 | $4,750,000 | $0 | 28 | Feb 6, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1596812/000114420414008309/0001144204-14-008309-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Paul Firuta | Executive Officer |  |
| Theresa M. Stevens | Executive Officer |  |
| Robert Cook | Executive Officer |  |
| Dalia I. H. Megiddo | Director |  |
| Warren Wasiewski | Executive Officer |  |
| Michael M. Burshtine | Director |  |
| Leigh M. Cherry | Executive Officer |  |
| Fredric Price | Executive Officer, Director |  |
| Ran Nusbaum | Director |  |
| Thomas I. H. Dubin | Director |  |
| Isaac I. H. Krymolowski | Director |  |
| Udi Gilboa | Director |  |
| Colin Foster | Executive Officer, Director |  |
| Gili M. Cohen | Director |  |
| Marlene Haffner | Director |  |

## Other pharmaceuticals companies in Connecticut that filed recently

- [Thetis Pharmaceuticals LLC](https://specstream.ai/data/form-d/company/thetis-pharmaceuticals-llc-1528491) $560,300 · Oct 13, 2026
- [Inventure, LLC](https://specstream.ai/data/form-d/company/inventure-llc-1706556) $82,345 · Sep 3, 2026

[Every Form D from the week of Mar 28, 2016](https://specstream.ai/data/form-d/week/2016-03-28) · [All recent filings in Connecticut](https://specstream.ai/data/form-d/state/connecticut) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what BIO BLAST PHARMA LTD. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).